Is hypercholesterolemia a risk factor for Alzheimer's disease?

被引:30
作者
Wood, WG
Igbavboa, U
Eckert, GP
Johnson-Anuna, LN
Müller, WE
机构
[1] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA
[2] VA Med Ctr, Geriat Res Educ & Clin Ctr, Minneapolis, MN 55455 USA
[3] Goethe Univ Frankfurt, Bioctr Niederursel, Dept Pharmacol, D-6000 Frankfurt, Germany
关键词
amyloid beta-protein; Alzheimer's disease; apolipoprotein E; cholesterol; lipoproteins; statins; SYNAPTIC PLASMA-MEMBRANES; COA REDUCTASE INHIBITORS; LOW-DENSITY-LIPOPROTEIN; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN-E; CEREBROSPINAL-FLUID; APOE GENOTYPE; CHOLESTEROL; BRAIN; POPULATION;
D O I
10.1385/MN:31:1-3:185
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is considerable attention being given to the association of Alzheimer's disease and cholesterol homeostasis. To that end, some have suggested that elevated cholesterol levels are a risk factor for Alzheimer's disease. If elevated cholesterol is a risk factor for Alzheimer's disease, then it would be expected that patients with Alzheimer's disease would have elevated serum and brain cholesterol levels. Studies were reviewed that have examined cholesterol levels in Alzheimer's patients and control subjects, including prospective studies, and based on that review, the conclusion is reached that the majority of studies do not support elevated cholesterol levels in serum and brain as a risk factor for Alzheimer's disease. Alternative hypotheses are discussed, including cholesterol domains and subgroups of individuals with hypercholesteremia.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 48 条
  • [1] [Anonymous], NAT HLTH NUTR EX SUR
  • [2] Cholesterol in Alzheimer's disease and tauopathy
    Burns, M
    Duff, K
    [J]. ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 : 367 - 375
  • [3] Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
    Cutler, RG
    Kelly, J
    Storie, K
    Pedersen, WA
    Tammara, A
    Hatanpaa, K
    Troncoso, JC
    Mattson, MP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (07) : 2070 - 2075
  • [4] Demeester N, 2000, J LIPID RES, V41, P963
  • [5] Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus:: Specific changes in Alzheimer's disease
    Eckert, GP
    Cairns, NJ
    Maras, A
    Gattaz, WF
    Müller, WE
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (04) : 181 - 186
  • [6] Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease:: A population-based study of African Americans
    Evans, RM
    Emsley, CL
    Gao, S
    Sahota, A
    Hall, KS
    Farlow, MR
    Hendrie, H
    [J]. NEUROLOGY, 2000, 54 (01) : 240 - 242
  • [7] Human and murine ApoE markedly alters Aβ metabolism before and after plaque formation in a mouse model of Alzheimer's disease
    Fagan, AM
    Watson, M
    Parsadanian, M
    Bales, KR
    Paul, SM
    Holtzman, DM
    [J]. NEUROBIOLOGY OF DISEASE, 2002, 9 (03) : 305 - 318
  • [8] Frikke-Schmidt R, 2000, J LIPID RES, V41, P1812
  • [9] Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors
    Hamelin, BA
    Turgeon, J
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (01) : 26 - 37
  • [10] Bridging the gap: Dynamics as a unified view of cognition
    Harter, D
    Graesser, AC
    Franklin, S
    [J]. BEHAVIORAL AND BRAIN SCIENCES, 2001, 24 (01) : 45 - +